Resonant Medical's Second Annual Breakfast Forum: Breast Image Guided Radiotherapy

Boston, MA – September 22, 2008  Resonant Medical hosted the second annual Breast Image-Guided Radiotherapy Symposium at the 50th annual ASTRO meeting held in Boston. At this Symposium American and International Radiation Oncologists discussed progress and innovations in image guidance in the planning and delivery of radiotherapy to breast cancer patients.

Panelists presented their thoughts and experiences on using the latest available techniques and products in this new era of accurate and selective Breast Image Guided Radiotherapy (IGRT) treatments

Distinguished speakers included:
   Dr. Pauline Truong, Radiation Oncologist, Vancouver Island Cancer Center
   Dr. Khalil Sultanem, Radiation Oncologist, McGill University Health Centre - JGH
   Dr. Coral Quiet, Radiation Oncologist, Arizona Oncology Services
   Dr. Manjeet Chadha, Radiation Oncologist, Beth Israel Medical Center

Resonant Medical was also demonstrating its second generation of breast solutions at ASTRO 2008. This new generation of product builds on the successful clinical trial results and offers optimized electron boost procedures, accurate Partial Breast lumpectomy localization and improved tools for breast volume study measurements.

About Resonant Medical
Resonant Medical (Montreal, Canada) develops, manufactures and commercializes 3D ultrasound image-guided adaptive radiotherapy products. Originally developed at McGill University Health Center, Resonant's technologies are available in more than 50 cancer centers in the U.S., Canada and Europe, helping cancer centers make significant improvements in radiation therapy planning, verification and delivery--advancing patient care.

For more information, please contact:

Michèle Jémus
Chief Financial Officer
Resonant Medical
M.: 514.518-0449
T.: 514-985-2442 x 270
F.: 514.985-9662
mjemus@resonantmedical.com